ATXN1 and hypopigmentation, organomegaly, and delayed myelination and development: The hypertrophy identified here appears strikingly similar to this well-described pathology, suggesting that SCA1-associated IO dysfunction may constitute a novel cause of olivary neuron hypertrophy (as seen in early stages of HOD).